131I-rituximab for Relapsed or Refractory Marginal Zone B-cell Lymphoma
Clinical trial NCT01678404 · UNKNOWN
Trial details
- NCT number
- NCT01678404
- Sponsor
- Korea Cancer Center Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-10-01
- Primary completion
- 2014-09-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.